Experts announce findings on immunotherapy, a breast cancer breakthrough and the value of exercise
Doctors, scientists and researchers shared new findings on ways to tackle cancer at the 2025 American Society of Clinical Oncology annual meeting, the world’s largest cancer conference.
The event in Chicago, attended by about 44,000 health professionals, featured more than 200 sessions on this year’s theme, Driving Knowledge to Action: Building a Better Future. Here is a roundup of the key studies.
An immunotherapy drug could help some cancer patients live years longer without the disease getting worse or coming back, a trial found.
Pembrolizumab, sold under the brand name Keytruda, kept head and neck cancers at bay for five years, compared with 30 months with standard care. It also cut the risk of the disease returning in another part of the body.
